|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:TOX2-EIF5A (FusionGDB2 ID:92515) |
Fusion Gene Summary for TOX2-EIF5A |
Fusion gene summary |
Fusion gene information | Fusion gene name: TOX2-EIF5A | Fusion gene ID: 92515 | Hgene | Tgene | Gene symbol | TOX2 | EIF5A | Gene ID | 84969 | 143244 |
Gene name | TOX high mobility group box family member 2 | eukaryotic translation initiation factor 5A like 1 | |
Synonyms | C20orf100|GCX-1|GCX1|dJ1108D11.2|dJ495O3.1 | EIF5A|EIF5AP1|bA342M3.3|eIF-4D|eIF-5A|eIF-5A-1|eIF-5A1 | |
Cytomap | 20q13.12 | 10q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | TOX high mobility group box family member 2granulosa cell HMG box 1 | eukaryotic translation initiation factor 5A-1-likeEukaryotic translation initiation factor 5A-1Rev-binding factoreukaryotic translation initiation factor 5A pseudogene 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q6IS14 | |
Ensembl transtripts involved in fusion gene | ENST00000341197, ENST00000423191, ENST00000372999, ENST00000358131, ENST00000435864, | ENST00000336452, ENST00000336458, ENST00000576930, ENST00000572815, ENST00000573542, ENST00000419711, ENST00000571955, ENST00000416016, | |
Fusion gene scores | * DoF score | 5 X 5 X 3=75 | 9 X 5 X 8=360 |
# samples | 5 | 9 | |
** MAII score | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/360*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TOX2 [Title/Abstract] AND EIF5A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | TOX2(42635432)-EIF5A(7212934), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TOX2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 25352127 |
Fusion gene breakpoints across TOX2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across EIF5A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-J4-A67N-01A | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
Top |
Fusion Gene ORF analysis for TOX2-EIF5A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000341197 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000336458 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000576930 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000572815 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000573542 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000419711 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000571955 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000341197 | ENST00000416016 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
In-frame | ENST00000423191 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000336458 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000576930 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000572815 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000573542 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000419711 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000571955 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000423191 | ENST00000416016 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
In-frame | ENST00000372999 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000336458 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000576930 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000572815 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000573542 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000419711 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000571955 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000372999 | ENST00000416016 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
In-frame | ENST00000358131 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000336458 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000576930 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000572815 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000573542 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000419711 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000571955 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
5CDS-5UTR | ENST00000358131 | ENST00000416016 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-3CDS | ENST00000435864 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000336458 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000576930 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000572815 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000573542 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000419711 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000571955 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
intron-5UTR | ENST00000435864 | ENST00000416016 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000341197 | TOX2 | chr20 | 42635432 | + | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 1570 | 439 | 28 | 924 | 298 |
ENST00000423191 | TOX2 | chr20 | 42635432 | + | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 1502 | 371 | 86 | 856 | 256 |
ENST00000372999 | TOX2 | chr20 | 42635432 | + | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 1610 | 479 | 140 | 964 | 274 |
ENST00000358131 | TOX2 | chr20 | 42635432 | + | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 1777 | 646 | 169 | 1131 | 320 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000341197 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + | 0.001130666 | 0.99886936 |
ENST00000423191 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + | 0.006505524 | 0.99349445 |
ENST00000372999 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + | 0.006356164 | 0.9936439 |
ENST00000358131 | ENST00000336452 | TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212934 | + | 0.003068025 | 0.9969319 |
Top |
Fusion Genomic Features for TOX2-EIF5A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212933 | + | 5.09E-08 | 1 |
TOX2 | chr20 | 42635432 | + | EIF5A | chr17 | 7212933 | + | 5.09E-08 | 1 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TOX2-EIF5A |
Go to FGviewer for the breakpoints of chr20:42635432-chr17:7212934 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | EIF5A |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. Functions as a regulator of apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000341197 | + | 3 | 9 | 76_114 | 137.0 | 507.0 | Region | Required for transcriptional activation |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000358131 | + | 3 | 8 | 76_114 | 146.0 | 489.0 | Region | Required for transcriptional activation |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000336452 | 0 | 6 | 20_90 | 23.0 | 357.3333333333333 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000336458 | 0 | 6 | 20_90 | 0 | 239.66666666666666 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000416016 | 0 | 6 | 20_90 | 0 | 298.0 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000419711 | 0 | 6 | 20_90 | 0 | 319.6666666666667 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000571955 | 1 | 7 | 20_90 | 0 | 319.6666666666667 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000573542 | 0 | 6 | 20_90 | 0 | 245.66666666666666 | Region | Note=DOHH-binding | |
Tgene | EIF5A | chr20:42635432 | chr17:7212934 | ENST00000576930 | 1 | 7 | 20_90 | 0 | 295.3333333333333 | Region | Note=DOHH-binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000341197 | + | 3 | 9 | 245_250 | 137.0 | 507.0 | Compositional bias | Note=Poly-Lys |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000341197 | + | 3 | 9 | 372_456 | 137.0 | 507.0 | Compositional bias | Note=Pro-rich |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000358131 | + | 3 | 8 | 245_250 | 146.0 | 489.0 | Compositional bias | Note=Poly-Lys |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000358131 | + | 3 | 8 | 372_456 | 146.0 | 489.0 | Compositional bias | Note=Pro-rich |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000372999 | + | 4 | 10 | 245_250 | 95.0 | 465.0 | Compositional bias | Note=Poly-Lys |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000372999 | + | 4 | 10 | 372_456 | 95.0 | 465.0 | Compositional bias | Note=Pro-rich |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000423191 | + | 3 | 9 | 245_250 | 95.0 | 465.0 | Compositional bias | Note=Poly-Lys |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000423191 | + | 3 | 9 | 372_456 | 95.0 | 465.0 | Compositional bias | Note=Pro-rich |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000341197 | + | 3 | 9 | 255_323 | 137.0 | 507.0 | DNA binding | HMG box |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000358131 | + | 3 | 8 | 255_323 | 146.0 | 489.0 | DNA binding | HMG box |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000372999 | + | 4 | 10 | 255_323 | 95.0 | 465.0 | DNA binding | HMG box |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000423191 | + | 3 | 9 | 255_323 | 95.0 | 465.0 | DNA binding | HMG box |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000341197 | + | 3 | 9 | 223_252 | 137.0 | 507.0 | Motif | Nuclear localization signal |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000358131 | + | 3 | 8 | 223_252 | 146.0 | 489.0 | Motif | Nuclear localization signal |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000372999 | + | 4 | 10 | 223_252 | 95.0 | 465.0 | Motif | Nuclear localization signal |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000423191 | + | 3 | 9 | 223_252 | 95.0 | 465.0 | Motif | Nuclear localization signal |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000372999 | + | 4 | 10 | 76_114 | 95.0 | 465.0 | Region | Required for transcriptional activation |
Hgene | TOX2 | chr20:42635432 | chr17:7212934 | ENST00000423191 | + | 3 | 9 | 76_114 | 95.0 | 465.0 | Region | Required for transcriptional activation |
Top |
Fusion Gene Sequence for TOX2-EIF5A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000341197_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(transcript)=1570nt_BP=439nt AGCCGCCGCCGCCGCCGCCGCGCCCGCCATGGACGTCCGCCTGTACCCCTCGGCGCCCGCGGTGGGCGCGCGGCCCGGGGCCGAGCCGGC CGGCCTGGCGCACCTGGACTATTACCACGGCGGCAAGTTTGATGGTGACAGTGCCTACGTGGGGATGAGTGACGGAAACCCAGAGCTCCT GTCAACCAGCCAGACCTACAACGGCCAGAGCGAGAACAACGAAGACTATGAGATCCCCCCGATAACACCTCCCAACCTCCCGGAGCCATC CCTCCTGCACCTGGGGGACCACGAAGCCAGCTACCACTCGCTGTGCCACGGCCTCACCCCCAACGGTCTGCTCCCTGCCTACTCCTATCA GGCCATGGACCTCCCAGCCATCATGGTGTCCAACATGCTAGCACAGGACAGCCACCTGCTGTCGGGCCAGCTGCCCACGTTGGAATCGAA GCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCTTCCCAATGCAGTGCTCAGCATTACGTAA GAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGACTGGCAAGCACGGCCACGCCAAGGTCCA TCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAACATCAAAAGGAA TGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGGTACGAGAGGACCTTCGTCTCCCTGAGGG AGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGCTGTCTGCCATGACAGAGGAGGCAGCTGT TGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCCTCTGAACCTGCAGAGGCCCCCTCCCCGA GCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTTTATTTTGGTTTTCCCCACCCCCTCAATC TGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCTTGGTGAAGCTGCCCTCCTCTTCTCCCCT CACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTTTTTTTTTTTTTTAATTCAATCTGGAATC AGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCCCCTGTTGCCTATAGCCCTTTACCCTGAG CACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTTTAGATGGGGAGGGAAGAGGAGGAGAGGG GAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTCCCTGCGGGCTCTCTCCCCGACACATTTG >In-frame_ENST00000341197_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(amino acids)=298AA_start in transcript=28_stop in transcript=924 MDVRLYPSAPAVGARPGAEPAGLAHLDYYHGGKFDGDSAYVGMSDGNPELLSTSQTYNGQSENNEDYEIPPITPPNLPEPSLLHLGDHEA SYHSLCHGLTPNGLLPAYSYQAMDLPAIMVSNMLAQDSHLLSGQLPTLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGR PCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGKEIEQK -------------------------------------------------------------- >In-frame_ENST00000423191_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(transcript)=1502nt_BP=371nt AGCGCGCGTGGGTTTCCCGCAGCCCTGGCGCAGACGCGTGGGCTCCGTGGCGATGCGGGTTTGATGGTGACAGTGCCTACGTGGGGATGA GTGACGGAAACCCAGAGCTCCTGTCAACCAGCCAGACCTACAACGGCCAGAGCGAGAACAACGAAGACTATGAGATCCCCCCGATAACAC CTCCCAACCTCCCGGAGCCATCCCTCCTGCACCTGGGGGACCACGAAGCCAGCTACCACTCGCTGTGCCACGGCCTCACCCCCAACGGTC TGCTCCCTGCCTACTCCTATCAGGCCATGGACCTCCCAGCCATCATGGTGTCCAACATGCTAGCACAGGACAGCCACCTGCTGTCGGGCC AGCTGCCCACGTTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCTTCCCAA TGCAGTGCTCAGCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGACTGGCA AGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATAATATGG ATGTCCCCAACATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGGTACGAG AGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGCTGTCTG CCATGACAGAGGAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCCTCTGAA CCTGCAGAGGCCCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTTTATTTT GGTTTTCCCCACCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCTTGGTGA AGCTGCCCTCCTCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTTTTTTTT TTTTTTAATTCAATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCCCCTGTT GCCTATAGCCCTTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTTTAGATG GGGAGGGAAGAGGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTCCCTGCG >In-frame_ENST00000423191_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(amino acids)=256AA_start in transcript=86_stop in transcript=856 MSDGNPELLSTSQTYNGQSENNEDYEIPPITPPNLPEPSLLHLGDHEASYHSLCHGLTPNGLLPAYSYQAMDLPAIMVSNMLAQDSHLLS GQLPTLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHN -------------------------------------------------------------- >In-frame_ENST00000372999_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(transcript)=1610nt_BP=479nt CGCAGCCCTGGCGCAGACGCGTGGGCTCCGTGGCGATGCGGGGTGTTGCCTGAGGCTCCACTGAAGCTATGGCATAATTTGCAGAATTTG CACTTCATTACTTTTCTGAAATTCAAACAAATTCTGAAACTGCACGAGTTCTGGCTGAGAGCTGTGGATCTGTGCATTTTGATGGTGACA GTGCCTACGTGGGGATGAGTGACGGAAACCCAGAGCTCCTGTCAACCAGCCAGACCTACAACGGCCAGAGCGAGAACAACGAAGACTATG AGATCCCCCCGATAACACCTCCCAACCTCCCGGAGCCATCCCTCCTGCACCTGGGGGACCACGAAGCCAGCTACCACTCGCTGTGCCACG GCCTCACCCCCAACGGTCTGCTCCCTGCCTACTCCTATCAGGCCATGGACCTCCCAGCCATCATGGTGTCCAACATGCTAGCACAGGACA GCCACCTGCTGTCGGGCCAGCTGCCCACGTTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGG CCTCAGCCACCTTCCCAATGCAGTGCTCAGCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGT CTACTTCGAAGACTGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCC CGTCAACTCATAATATGGATGTCCCCAACATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGG ACAGCGGGGAGGTACGAGAGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCC TGATCACGGTGCTGTCTGCCATGACAGAGGAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGG CAGCAGTGATCCTCTGAACCTGCAGAGGCCCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATT TATTTGACGTTTTATTTTGGTTTTCCCCACCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCG AAGCTGTGGCCTTGGTGAAGCTGCCCTCCTCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTT AGTCTTTTTTTTTTTTTTTTTTTTAATTCAATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCC CTGGTCTGGTCCCCTGTTGCCTATAGCCCTTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTC CCCAAACCCCTTTAGATGGGGAGGGAAGAGGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGG >In-frame_ENST00000372999_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(amino acids)=274AA_start in transcript=140_stop in transcript=964 MAESCGSVHFDGDSAYVGMSDGNPELLSTSQTYNGQSENNEDYEIPPITPPNLPEPSLLHLGDHEASYHSLCHGLTPNGLLPAYSYQAMD LPAIMVSNMLAQDSHLLSGQLPTLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVG IDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGKEIEQKYDCGEEILITVLSAMTEEAAVAIK -------------------------------------------------------------- >In-frame_ENST00000358131_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(transcript)=1777nt_BP=646nt ACCAGGAGCTCCGAACACGCAGGCCCAAATTGGAATAGGAGATGGATTTTGATAAAAGAGGTTAAATAACAGGTTTTTCCATTTCACCTT ATACGAATGGGATGGGGGGTGGGGGTGCTGGGCCTCCAGCCAATAGAGGACCAAGAGTTGTCAGGAGGGCTTATAAAGCTTGCTATTTCT GGCATTTTTTCCTCTTTCTCTGCTGATTATGCAGCAGACTCGCACAGAGGCTGTCGCGGGCGCGTTCTCTCGCTGCCTGGGCTTCTGTGG AATGAGACTCGGGCTCCTTCTACTTGCAAGACACTGGTGCATTGCAGGTGTGTTTCCGCAGAAGTTTGATGGTGACAGTGCCTACGTGGG GATGAGTGACGGAAACCCAGAGCTCCTGTCAACCAGCCAGACCTACAACGGCCAGAGCGAGAACAACGAAGACTATGAGATCCCCCCGAT AACACCTCCCAACCTCCCGGAGCCATCCCTCCTGCACCTGGGGGACCACGAAGCCAGCTACCACTCGCTGTGCCACGGCCTCACCCCCAA CGGTCTGCTCCCTGCCTACTCCTATCAGGCCATGGACCTCCCAGCCATCATGGTGTCCAACATGCTAGCACAGGACAGCCACCTGCTGTC GGGCCAGCTGCCCACGTTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCTT CCCAATGCAGTGCTCAGCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGAC TGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATAA TATGGATGTCCCCAACATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGGT ACGAGAGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGCT GTCTGCCATGACAGAGGAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCCT CTGAACCTGCAGAGGCCCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTTT ATTTTGGTTTTCCCCACCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCTT GGTGAAGCTGCCCTCCTCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTTT TTTTTTTTTTTAATTCAATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCCC CTGTTGCCTATAGCCCTTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTTT AGATGGGGAGGGAAGAGGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTCC >In-frame_ENST00000358131_ENST00000336452_TCGA-J4-A67N-01A_TOX2_chr20_42635432_+_EIF5A_chr17_7212934_length(amino acids)=320AA_start in transcript=169_stop in transcript=1131 MLFLAFFPLSLLIMQQTRTEAVAGAFSRCLGFCGMRLGLLLLARHWCIAGVFPQKFDGDSAYVGMSDGNPELLSTSQTYNGQSENNEDYE IPPITPPNLPEPSLLHLGDHEASYHSLCHGLTPNGLLPAYSYQAMDLPAIMVSNMLAQDSHLLSGQLPTLESKPLKMADDLDFETGDAGA SATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TOX2-EIF5A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TOX2-EIF5A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TOX2-EIF5A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | EIF5A | C0007097 | Carcinoma | 1 | CTD_human |
Tgene | EIF5A | C0022548 | Keloid | 1 | CTD_human |
Tgene | EIF5A | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Tgene | EIF5A | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | EIF5A | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Tgene | EIF5A | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Tgene | EIF5A | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Tgene | EIF5A | C0205699 | Carcinomatosis | 1 | CTD_human |
Tgene | EIF5A | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |